Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: HIKMA PHARMACEUTICALS USA INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-16 to 2024-02-22
Current total value of award: $114.57
Description: 4563719487!HYDROMORPHONE 2 MG/ML VIALML